accountBy Pat Wechsler and Meg Tirrell (Updates with CEO comment in the seventh paragraph.) Nov. 18 (Bloomberg) -- Cardinal Health Inc., the Dublin, Ohio-based drug distributor, said it plans to buy closely held Kinray Inc. for $1.3 billion to expand in retail...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Cardinal Health to Buy Kinray for $1.3 Billion Cash
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account